- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -
Patients With Glaucoma Sought for Clinical Trial Underway at Yale School of Medicine to Establish Ability of SOLX Gold Shunt to Reduce IOP
Posted By Dr. Ari Weitzner On August 16, 2011 @ 5:57 am In Clinical Trials,Glaucoma,New Technologies,Research | Comments Disabled
The Yale School of Medicine is currently seeking volunteers to participate in a Phase III clinical trial commenced in January 2011 to evaluate the SOLX Gold Shunt for the reduction of intraocular pressue (IOL) in refractory glaucoma where medical and conventional surgical treatments have failed (see our 2009 blog post reporting the approval of the SOLX gold shunt as a treatment for glaucoma in Canada [1]).
Yale is still recruiting volunteers. Participation in the trial is available to individual 21 years or older (male or female) meeting the following medical criteria:
For further details on the clinical trial, and contact information, click here [2] (government website) or here [3] (Yale website).
Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com
URL to article: http://eyedocnews.com/005863-volunteers-sought-for-clinical-trial-underway-at-yale-school-of-medicine-to-establish-ability-of-solx-gold-shunt-to-reduce-iop-in-eyes-with-refractory-glaucoma/
URLs in this post:
[1] approval of the SOLX gold shunt as a treatment for glaucoma in Canada: http://eyedocnews.com/001950-solx-gold-shunt-cleared-in-canada-for-surgical-treatment-of-glaucoma/
[2] here: http://clinicaltrials.gov/ct2/show/NCT01282346
[3] here: http://yalestudies.org/clinicalTrials/displayTrial.asp?nctID=NCT01282346
Click here to print.
Copyright © 2008 Eye Doc Talk. All rights reserved.